title: Is yearly intravenous zoledronic acid comparable to weekly oral alendronate for postmenopausal osteoporosis?
authors.affiliation: Department of Internal Medicine at the University of Florence, Florence, Italy. m.brandi@dmi.unifi.it
authors.forename: Maria Luisa
authors.initials: ML
authors.lastname: Brandi